Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes

Sridevi Devaraj1, Peter Tobias, Ishwarlal Jialal

  • 1Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis, Medical Center, Sacramento CA, USA.

Cytokine
|April 19, 2011
PubMed

Insights

Toll-like receptor 4 (TLR4) contributes to inflammation in type 1 diabetes (T1DM). Genetic deficiency of TLR4 significantly reduces inflammatory markers in a mouse model of T1DM, suggesting TLR4 plays a key role in diabetes-related inflammation.

Area of Science:

  • Immunology
  • Endocrinology
  • Pathophysiology

Background:

  • Type 1 diabetes (T1DM) is characterized by a pro-inflammatory state and increased vascular complications.
  • Elevated Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) expression and activation are observed in T1DM, particularly with microvascular complications.

Purpose of the Study:

  • To investigate whether genetic deficiency of TLR4 (TLR4 knockout) attenuates the heightened inflammation associated with T1DM.
  • To utilize the streptozotocin-induced diabetic mouse model to assess the role of TLR4 in T1DM-related inflammation.

Main Methods:

  • Comparison of wild-type (WT) and TLR4 knockout (TLR4(-/-)) mice in both native and streptozotocin-induced diabetic states.
  • Measurement of TLR2 and TLR4 expression, inflammatory signaling pathway components (MyD88, IRAK-1, Trif, IRF3, NF-κB), and cytokine levels (IL-1β, IL-6, KC/IL-8, IP-10, MCP-1, IFN-β, TNF-α).

Main Results:

  • Diabetic WT mice showed increased TLR2 and TLR4 expression, while diabetic TLR4(-/-) mice showed increased TLR2 but not TLR4.
  • Key inflammatory signaling pathway components and NF-κB activity were significantly reduced in diabetic TLR4(-/-) mice compared to diabetic WT mice.
  • Pro-inflammatory cytokine levels were significantly elevated in diabetic WT mice and markedly attenuated in diabetic TLR4(-/-) mice.

Conclusions:

  • TLR4 plays a significant role in mediating the pro-inflammatory state observed in type 1 diabetes.
  • Genetic deficiency of TLR4 effectively attenuates inflammation in the context of T1DM, highlighting TLR4 as a potential therapeutic target.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...